A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

For Black, Hispanic and LGBTQ+ patients, accessing quality menopause care is a challenge both inside and outside clinical ...

National Minority Mental Health Month emphasizes the persistent mental health disparities among US racial and ethnic ...

On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...

More women vs. men veterans with COPD received spirometry and tobacco cessation interventions, but more men received correct ...

What does it feel like to be the only one in the room and expected to speak for everyone who looks like you?” For many Black ...

An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...

( NewsNation) — The head of the U.S. Food and Drug Administration signaled Thursday that he supports changing or removing the ...

The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for ...

Treatment options for patients with moderately to severely active Crohn's disease have expanded in the past decade, with ...

Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...